Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2021-11-29 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for a specific period (01.10.2021 to 31.10.2021). It is addressed to stock exchanges and signed by the company secretary. The document is short (3270 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance certificate related to securities and share dematerialization, fitting best under Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit other categories.
2021-11-29 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended September 30, 2021, submitted pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on transactions and balances with related parties, including key management personnel and independent directors. The document is not an announcement of a report but the actual disclosure with substantive financial data for a half-year period. This fits the category of a regulatory filing related to financial disclosures but does not match the definitions of Annual Report, Interim Report, or Earnings Release. It is a specific regulatory disclosure under SEBI regulations, which is best classified under Regulatory Filings (RNS) as it does not fit other categories like MDA or AR. The document length (5892 characters) and content confirm it is a full disclosure document, not a brief announcement or certification.
2021-11-29 English
We are enclosing herewith Certificate dated November 3, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.10.2021 to 31.10.2021. It is addressed to stock exchanges and signed by the company secretary. The document is short (3270 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2021-11-29 English
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended September 30, 2021, submitted pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on transactions with related parties, including purchases, sales, reimbursements, contributions to trusts, and balances receivable and payable. The document is not an annual or interim report but a regulatory disclosure specific to related party transactions. It is not a report publication announcement or a certification. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-11-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 39(3). The content is about notifying the exchange of a shareholder's lost share certificates, which is a regulatory disclosure related to share ownership but not a financial report, earnings release, or management information. It is not an announcement of voting results, capital changes, or insider dealings. The document is short (1569 characters) and is a regulatory notification to the exchange. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-11-17 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share certificate loss reporting. The content is an announcement of a specific event (loss of share certificates) and does not contain financial data, management discussion, or report publication. It is not a financial report, earnings release, or management information. It is a regulatory announcement related to shareholding records and compliance disclosures. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-11-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.